<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="http://activeamericas.com/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>http://activeamericas.com/blog/medicinal-chemistry-fte/</loc></url><url><loc>http://activeamericas.com/blog/custom-chemistry-chemistry-fte-resynthesis/</loc></url><url><loc>http://activeamericas.com/blog/in-silico-drug-design-cadd/</loc></url><url><loc>http://activeamericas.com/blog/discovery-biology-biology-fte-in-vitro-studies/</loc></url><url><loc>http://activeamericas.com/blog/novel-inhibitors-of-ovarian-cancer-from-chemdiv-collection/</loc></url><url><loc>http://activeamericas.com/blog/chemdiv-company-in-publications-and-patents/</loc></url><url><loc>http://activeamericas.com/blog/covalent-serine-binders-library/</loc></url><url><loc>http://activeamericas.com/blog/isomerases/</loc></url><url><loc>http://activeamericas.com/blog/analogues-of-approved-drugs-library/</loc></url><url><loc>http://activeamericas.com/blog/cpla2-inhibitors/</loc></url><url><loc>http://activeamericas.com/blog/cysteine-targeted-covalent-library/</loc></url><url><loc>http://activeamericas.com/blog/inhibitors-library-rna-protein-interaction/</loc></url><url><loc>http://activeamericas.com/blog/ligand-gated/</loc></url><url><loc>http://activeamericas.com/blog/ligases/</loc></url><url><loc>http://activeamericas.com/blog/lyases/</loc></url><url><loc>http://activeamericas.com/blog/natural-compounds-library/</loc></url><url><loc>http://activeamericas.com/blog/oxidoreductases/</loc></url><url><loc>http://activeamericas.com/blog/phosphodiesterases/</loc></url><url><loc>http://activeamericas.com/blog/protease-library/</loc></url><url><loc>http://activeamericas.com/blog/ror%ce%b3-library/</loc></url><url><loc>http://activeamericas.com/blog/sigma-opioid-receptors/</loc></url><url><loc>http://activeamericas.com/blog/thrombopoietin-receptors/</loc></url><url><loc>http://activeamericas.com/blog/toll-like-and-il-1-receptors/</loc></url><url><loc>http://activeamericas.com/blog/transferases/</loc></url><url><loc>http://activeamericas.com/blog/voltage-gated/</loc></url><url><loc>http://activeamericas.com/blog/developmental-pathway-hh-wnt-set/</loc></url><url><loc>http://activeamericas.com/blog/akt-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/allosteric-inhibitors/</loc></url><url><loc>http://activeamericas.com/blog/androgen-receptor-antagonists-library/</loc></url><url><loc>http://activeamericas.com/blog/angiogenesis-library/</loc></url><url><loc>http://activeamericas.com/blog/angiogenesis-library-2/</loc></url><url><loc>http://activeamericas.com/blog/anticancer-library/</loc></url><url><loc>http://activeamericas.com/blog/antimitotic-tubulin-library/</loc></url><url><loc>http://activeamericas.com/blog/aurora-libraries-aurora-a-b-kinases-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/autophagy-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/bcl2-ppi-inhibitors-library/</loc></url><url><loc>http://activeamericas.com/blog/c-met-library/</loc></url><url><loc>http://activeamericas.com/blog/carbonic-anhydrase-ii-library/</loc></url><url><loc>http://activeamericas.com/blog/cysteine-proteases-inhibitors-library/</loc></url><url><loc>http://activeamericas.com/blog/hsp90-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/inhibitors-of-beta-catenin-signaling/</loc></url><url><loc>http://activeamericas.com/blog/kras-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/mdm2-p53-interaction-inhibitors-library/</loc></url><url><loc>http://activeamericas.com/blog/mef2-hdac-class-ii-modulators-library/</loc></url><url><loc>http://activeamericas.com/blog/notum-wnt-signaling-library/</loc></url><url><loc>http://activeamericas.com/blog/nucleic-acid-ligands/</loc></url><url><loc>http://activeamericas.com/blog/nucleoside-mimetics-library/</loc></url><url><loc>http://activeamericas.com/blog/pi3k-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/proline-kinase-library/</loc></url><url><loc>http://activeamericas.com/blog/protein-arginine-methyltransferases-library/</loc></url><url><loc>http://activeamericas.com/blog/protein-kinases-inhibitors-library/</loc></url><url><loc>http://activeamericas.com/blog/purine-based-nucleoside-mimetics-library/</loc></url><url><loc>http://activeamericas.com/blog/serine-proteases-inhibitors-library/</loc></url><url><loc>http://activeamericas.com/blog/sh2-ptb-focused-library/</loc></url><url><loc>http://activeamericas.com/blog/cardiovascular-library/</loc></url><url><loc>http://activeamericas.com/blog/lipid-metabolism-library/</loc></url><url><loc>http://activeamericas.com/blog/macl-gpib-alpha-interaction-library/</loc></url><url><loc>http://activeamericas.com/blog/purinergic-library/</loc></url><url><loc>http://activeamericas.com/blog/regenerative-medicine-focused-library/</loc></url><url><loc>http://activeamericas.com/blog/gpcr-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/3clpro-library/</loc></url><url><loc>http://activeamericas.com/blog/ace2-library/</loc></url><url><loc>http://activeamericas.com/blog/anti-hiv1-library/</loc></url><url><loc>http://activeamericas.com/blog/anti-infective-library/</loc></url><url><loc>http://activeamericas.com/blog/anti-inflammatory-library/</loc></url><url><loc>http://activeamericas.com/blog/antibacterial-compounds-library/</loc></url><url><loc>http://activeamericas.com/blog/antiviral-hbv-library/</loc></url><url><loc>http://activeamericas.com/blog/antiviral-library/</loc></url><url><loc>http://activeamericas.com/blog/coronavirus-library/</loc></url><url><loc>http://activeamericas.com/blog/immunological-library/</loc></url><url><loc>http://activeamericas.com/blog/plpro-library/</loc></url><url><loc>http://activeamericas.com/blog/mirna-targeted-small-molecule-library/</loc></url><url><loc>http://activeamericas.com/blog/mcl1-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/cns-bbb-library/</loc></url><url><loc>http://activeamericas.com/blog/cns-library/</loc></url><url><loc>http://activeamericas.com/blog/cns-mpo-library/</loc></url><url><loc>http://activeamericas.com/blog/cns-targets/</loc></url><url><loc>http://activeamericas.com/blog/ligand-gated-ion-channels-library/</loc></url><url><loc>http://activeamericas.com/blog/neurotransmitter-transporter-inhibitors-library/</loc></url><url><loc>http://activeamericas.com/blog/voltage-gated-ion-channel-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/gaba-library/</loc></url><url><loc>http://activeamericas.com/blog/ocular-diseases-small-molecules-library/</loc></url><url><loc>http://activeamericas.com/blog/adenosine-receptors-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/gpcr-family-a/</loc></url><url><loc>http://activeamericas.com/blog/gpcr-family-b/</loc></url><url><loc>http://activeamericas.com/blog/gpcr-family-%d1%81/</loc></url><url><loc>http://activeamericas.com/blog/gpcr-frizzled-family/</loc></url><url><loc>http://activeamericas.com/blog/gpcr-taste-family/</loc></url><url><loc>http://activeamericas.com/blog/neuropeptide-s-library/</loc></url><url><loc>http://activeamericas.com/blog/ion-channels-focused-library/</loc></url><url><loc>http://activeamericas.com/blog/dgk-inhibitors-library/</loc></url><url><loc>http://activeamericas.com/blog/kinases/</loc></url><url><loc>http://activeamericas.com/blog/type-ii-kinase-inhibitors-library/</loc></url><url><loc>http://activeamericas.com/blog/chelators-targeting-matrix-metalloproteinases-library/</loc></url><url><loc>http://activeamericas.com/blog/factor-xia-compounds-library/</loc></url><url><loc>http://activeamericas.com/blog/proteases/</loc></url><url><loc>http://activeamericas.com/blog/protein-tyrosine-phosphatase-non-receptor-type-ptpn-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/receptor-protein-tyrosine-phosphatases/</loc></url><url><loc>http://activeamericas.com/blog/glucocorticoid-receptors-library/</loc></url><url><loc>http://activeamericas.com/blog/rar-nuclear-receptors-ligands-library/</loc></url><url><loc>http://activeamericas.com/blog/arginase-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/brd4-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/indoleamine-23-dioxygenase-1-focused-library/</loc></url><url><loc>http://activeamericas.com/blog/integrin-receptors-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/sting-agonist-library/</loc></url><url><loc>http://activeamericas.com/blog/tlr-8-ligands-library/</loc></url><url><loc>http://activeamericas.com/blog/alpha-helix-mimetics-library/</loc></url><url><loc>http://activeamericas.com/blog/bromodomain-modulators-library/</loc></url><url><loc>http://activeamericas.com/blog/cyclic-ugi-ppi-library/</loc></url><url><loc>http://activeamericas.com/blog/eccentric-ppi-library/</loc></url><url><loc>http://activeamericas.com/blog/macrocycles-library/</loc></url><url><loc>http://activeamericas.com/blog/nonpeptide-peptidomimetics-ppi-library/</loc></url><url><loc>http://activeamericas.com/blog/pdz-ppi-library/</loc></url><url><loc>http://activeamericas.com/blog/peptidomimetic-library/</loc></url><url><loc>http://activeamericas.com/blog/peptidomimetics-of-beta-turn-motifs-library/</loc></url><url><loc>http://activeamericas.com/blog/ppi-helix-turn-3d-mimetics-library/</loc></url><url><loc>http://activeamericas.com/blog/ppi-inhibitors-tripeptide-mimetics/</loc></url><url><loc>http://activeamericas.com/blog/protein-protein-interaction-library/</loc></url><url><loc>http://activeamericas.com/blog/sh2-library/</loc></url><url><loc>http://activeamericas.com/blog/recognition-elements-ppi-library/</loc></url><url><loc>http://activeamericas.com/blog/spiro-library/</loc></url><url><loc>http://activeamericas.com/blog/anti-aging-library/</loc></url><url><loc>http://activeamericas.com/blog/epigenetics/</loc></url><url><loc>http://activeamericas.com/blog/epitranscriptome-focused-small-molecule-library/</loc></url><url><loc>http://activeamericas.com/blog/histone-deacetylases-hdac-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/3d-mimetics-ppi-library/</loc></url><url><loc>http://activeamericas.com/blog/rna-isosteric-trinucleotide-mimetics-library/</loc></url><url><loc>http://activeamericas.com/blog/beyond-the-flatland-library-sp3-enriched/</loc></url><url><loc>http://activeamericas.com/blog/covalent-inhibitors-library/</loc></url><url><loc>http://activeamericas.com/blog/indole-derivatives/</loc></url><url><loc>http://activeamericas.com/blog/steroid-like-compounds/</loc></url><url><loc>http://activeamericas.com/blog/3d-fragment-library/</loc></url><url><loc>http://activeamericas.com/blog/covalent-fragments-smart-library/</loc></url><url><loc>http://activeamericas.com/blog/crystallographic-and-19f-nmr-fragment-libraries/</loc></url><url><loc>http://activeamericas.com/blog/fragments-library/</loc></url><url><loc>http://activeamericas.com/blog/privileged-fragments-annotated-library/</loc></url><url><loc>http://activeamericas.com/blog/dark-chemical-matter-library/</loc></url><url><loc>http://activeamericas.com/blog/frequent-hitters-library/</loc></url><url><loc>http://activeamericas.com/blog/natural-product-based-library/</loc></url><url><loc>http://activeamericas.com/blog/triazoles/</loc></url><url><loc>http://activeamericas.com/blog/antifungal-library/</loc></url><url><loc>http://activeamericas.com/blog/antiparasite-library/</loc></url><url><loc>http://activeamericas.com/blog/new-agro-library/</loc></url><url><loc>http://activeamericas.com/blog/chemogenomic-annotated-library-for-phenotypic-screening/</loc></url><url><loc>http://activeamericas.com/blog/cns-annotated-library/</loc></url><url><loc>http://activeamericas.com/blog/cns-targets-activity-set/</loc></url><url><loc>http://activeamericas.com/blog/human-gpcr-annotated-library/</loc></url><url><loc>http://activeamericas.com/blog/human-ion-channels-annotated-library/</loc></url><url><loc>http://activeamericas.com/blog/human-kinases-annotated-library/</loc></url><url><loc>http://activeamericas.com/blog/human-phosphatases-annotated-library/</loc></url><url><loc>http://activeamericas.com/blog/human-receptors-annotated-library/</loc></url><url><loc>http://activeamericas.com/blog/human-transcription-factors-annotated-library/</loc></url><url><loc>http://activeamericas.com/blog/launched-clinically-evaluated-drugs-library/</loc></url><url><loc>http://activeamericas.com/blog/opportunistic-pathogens-of-immunocompromised-hosts-annotated-library/</loc></url><url><loc>http://activeamericas.com/blog/selective-target-activity-profiling-library/</loc></url><url><loc>http://activeamericas.com/blog/target-identification-phenotypic-screening-library-tips/</loc></url><url><loc>http://activeamericas.com/blog/therapeutical-diversity-annotated-library/</loc></url><url><loc>http://activeamericas.com/blog/100k-diverse-compounds-pre-plated-set/</loc></url><url><loc>http://activeamericas.com/blog/300k-representative-compounds-library-bemis-murcko-clustering-algorithm/</loc></url><url><loc>http://activeamericas.com/blog/3d-biodiversity-library/</loc></url><url><loc>http://activeamericas.com/blog/3d-diversity-natural-product-like-library/</loc></url><url><loc>http://activeamericas.com/blog/3d-pharmacophore-based-diversity-library/</loc></url><url><loc>http://activeamericas.com/blog/fast-follow-up-sar-diverse-screening-library/</loc></url><url><loc>http://activeamericas.com/blog/smarttm-library/</loc></url><url><loc>http://activeamericas.com/blog/mce-18-trends-in-medicinal-chemistry/</loc></url><url><loc>http://activeamericas.com/blog/representative-diversity-libraries/</loc></url><url><loc>http://activeamericas.com/blog/soluble-diversity-library/</loc></url><url><loc>http://activeamericas.com/blog/targeted-diversity-library/</loc></url><url><loc>http://activeamericas.com/blog/animal-models/</loc></url><url><loc>http://activeamericas.com/blog/toxicology-and-safety/</loc></url><url><loc>http://activeamericas.com/blog/adme-dmpk-in-vivo-studies/</loc></url><url><loc>http://activeamericas.com/blog/chemistry-manufacturing-and-controls/</loc></url><url><loc>http://activeamericas.com/blog/chemdiv-shares-an-update-on-its-cutting-edge-biology-facility-in-portugal/</loc></url><url><loc>http://activeamericas.com/blog/chemdiv-is-now-a-discovery-partner-with-gwynant-therapeutics-and-celyn-therapeutics/</loc></url><url><loc>http://activeamericas.com/blog/our-covalent-compound-library-is-now-available-in-a-ready-to-dock-format-for-biosolveit/</loc></url><url><loc>http://activeamericas.com/blog/methamphetamine-use-drove-surge-in-heart-failure-hospitalizations-costs-in-california/</loc></url><url><loc>http://activeamericas.com/blog/esteve-and-kowa-pharmaceuticals-america-enter-into-an-exclusive-license-and-commercialization-agreement-for-rights-to-e-58425-for-the-potential-management-of-acute-pain-in-the-united-states/</loc></url><url><loc>http://activeamericas.com/blog/new-article-a-selective-ligand-for-estrogen-receptor-proteins-discriminates-rapid-and-genomic-signaling/</loc></url><url><loc>http://activeamericas.com/blog/insilico-medicine-and-chemdiv-form-a-strategic-drug-discovery-service-alliance/</loc></url><url><loc>http://activeamericas.com/blog/ai-gets-access-to-big-novel-chemistry-space-for-quick-and-effective-drug-discovery/</loc></url><url><loc>http://activeamericas.com/blog/mmp-inhibitors/</loc></url><url><loc>http://activeamericas.com/blog/ha2-focused-library/</loc></url><url><loc>http://activeamericas.com/blog/g9a-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/cxcr4-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/dnmt-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/stem-cell-modulators-library/</loc></url><url><loc>http://activeamericas.com/blog/lysine-specific-histone-demethylases-kdm-library/</loc></url><url><loc>http://activeamericas.com/blog/calcium-channels-focused-library/</loc></url><url><loc>http://activeamericas.com/blog/htert-targeted-library/</loc></url><url><loc>http://activeamericas.com/blog/beta2-adrenoligands/</loc></url><url><loc>http://activeamericas.com/blog/apoptosis-focused-library/</loc></url><url><loc>http://activeamericas.com/blog/antibacterial-library/</loc></url><url><loc>http://activeamericas.com/blog/macrocyclic-peptidomimetics-library-design-and-synthesis/</loc></url><url><loc>http://activeamericas.com/blog/viriom-signed-licensing-agreement-for-indonesia-with-p-t-lloyd-pharma/</loc></url><url><loc>http://activeamericas.com/blog/meet-chemdiv-at-better-leads-better-drugs-innovation-in-screening-libraries/</loc></url><url><loc>http://activeamericas.com/blog/viriom-china-wins-award-at-2018-zhongguancun-international-frontier-science-and-technology-innovation-competition/</loc></url><url><loc>http://activeamericas.com/blog/torrey-pines-investments-i2020-accelerator-to-advance-snap-bios-selective-kinase-inhibitor-platform-for-treatment-of-endodermal-cancers-and-autoimmune-diseases/</loc></url><url><loc>http://activeamericas.com/blog/meet-chemdiv-at-7th-international-conference-on-multicomponent-reactions-and-related-chemistry/</loc></url><url><loc>http://activeamericas.com/blog/meet-chemdiv-at-efmc-ismc18-international-symposium-on-medicinal-chemistry/</loc></url><url><loc>http://activeamericas.com/blog/chemdiv-announces-expansion-of-multi-year-hit-identification-collaboration-with-janssen/</loc></url><url><loc>http://activeamericas.com/blog/regen-biopharma-inc-s-medicinal-chemistry-program-has-identified-additional-compounds-that-activate-nr2f6/</loc></url><url><loc>http://activeamericas.com/blog/chemdiv-dzne-and-torrey-pines-investment-launch-inflammasome-discovery-program-of-translational-collaboration-on-neurodegeneration/</loc></url><url><loc>http://activeamericas.com/blog/active-biotech-announce-results-in-arpeggio-phase-ii-trial-with-laquinimod-in-primary-progressive-ms/</loc></url><url><loc>http://activeamericas.com/blog/nature-communications-publishes-a-study-that-identified-small-molecule-which-imposes-metabolic-stress-and-cellular-death-in-malignant-cells/</loc></url><url><loc>http://activeamericas.com/blog/chemdiv-achieves-milestone-in-viriom-collaboration-on-elsulfavirine-vm1500a-long-acting-injectable-formulation-development/</loc></url><url><loc>http://activeamericas.com/blog/chemdiv-to-help-afraxis-advance-synaptic-profiling-platform-for-cns-drug-discovery/</loc></url><url><loc>http://activeamericas.com/blog/chemdiv-announces-multi-year-hit-identification-collaboration-with-janssen/</loc></url><url><loc>http://activeamericas.com/blog/regen-biopharma-begins-optimization-of-nr2f6-small-molecule-modulators/</loc></url><url><loc>http://activeamericas.com/blog/newvac-reports-primary-endpoint-met-in-phase-ii-clinical-trial-of-quisinostat-in-platinum-resistant-ovarian-cancer/</loc></url><url><loc>http://activeamericas.com/blog/viriom-announces-collaboration-with-nih-on-zika-and-other-major-viral-diseases/</loc></url><url><loc>http://activeamericas.com/blog/new-molecule-may-help-fight-obesity/</loc></url><url><loc>http://activeamericas.com/blog/trevi-therapeutics-announces-positive-results-from-phase-2-trial-in-prurigo-nodularis/</loc></url><url><loc>http://activeamericas.com/blog/chemdiv-is-presenting-at-the-scis-event-innovation-in-design-supply-and-acquisition-for-compound-screening-libraries-on-14th-september-2016-in-hatfield-uk/</loc></url><url><loc>http://activeamericas.com/blog/chemdiv-and-insilico-medicine-form-a-strategic-alliance-to-develop-oncology-focused-libraries-using-artificial-intelligence/</loc></url><url><loc>http://activeamericas.com/blog/satrx-llc-announces-first-registration-in-russia-of-satrx-gosogliptin-an-innovative-drug-for-treatment-of-type-2-diabetes/</loc></url><url><loc>http://activeamericas.com/blog/viriom-announces-receipt-of-funding-from-the-skolkovo-foundation-chemrar-and-torrey-pines-investment-to-develop-elpida-a-novel-preventive-and-long-acting-treatment-of-hiv-aids/</loc></url><url><loc>http://activeamericas.com/blog/2015-chinese-medicinal-chemistry-symposiumcmcs2015-5th-cpa-rsc-symposium-on-medicinal-chemistry-in-august/</loc></url><url><loc>http://activeamericas.com/blog/iressa-gefitinib-approved-by-the-u-s-food-and-drug-administration-for-first-line-treatment-of-advanced-egfr-mutation-positive-non-small-cell-lung-cancer/</loc></url><url><loc>http://activeamericas.com/blog/podophyllotoxin-featured-structure-of-the-month/</loc></url><url><loc>http://activeamericas.com/blog/10-08-2013-viriom-reports-clinical-efficacy-data-for-vm1500-a-new-hiv-nnrti/</loc></url><url><loc>http://activeamericas.com/blog/09-30-2013-chemdiv-launches-macrolead-tm-platform/</loc></url><url><loc>http://activeamericas.com/blog/risk-benefit-profiles-of-currently-approved-oral-antivirals-for-treatment-of-covid-19-similarities-and-differences/</loc></url><url><loc>http://activeamericas.com/blog/how-to-save-the-lives-of-people-with-cancer-who-are-not-cured/</loc></url><url><loc>http://activeamericas.com/blog/the-human-brain-has-learned-to-save-energy-on-signal-transmission/</loc></url><url><loc>http://activeamericas.com/blog/microneedle-patches-new-drug-carriers-improve-cancer-treatment/</loc></url><url><loc>http://activeamericas.com/blog/how-to-stop-cancer-attack-on-the-microtubules/</loc></url><url><loc>http://activeamericas.com/blog/central-nervous-system-drugs/</loc></url><url><loc>http://activeamericas.com/blog/scientists-have-created-bacteria-that-feed-cancer-fighting-immune-cells/</loc></url><url><loc>http://activeamericas.com/blog/chemical-database/</loc></url><url><loc>http://activeamericas.com/blog/scientists-launched-regeneration-after-a-heart-attack-and-healed-the-heart/</loc></url><url><loc>http://activeamericas.com/blog/a-molecule-that-can-cure-type-1-diabetes/</loc></url><url><loc>http://activeamericas.com/blog/protein-kinases/</loc></url><url><loc>http://activeamericas.com/blog/gaba-antagonists-convulsants-and-antidotes/</loc></url><url><loc>http://activeamericas.com/blog/combinatorial-libraries/</loc></url><url><loc>http://activeamericas.com/blog/vative-treatments-for-sickle-cell-disease/</loc></url><url><loc>http://activeamericas.com/blog/from-treating-diabetes-to-preventing-diabetes/</loc></url><url><loc>http://activeamericas.com/blog/molecule-that-is-capable-to-cure-obesity/</loc></url><url><loc>http://activeamericas.com/blog/dmso/</loc></url><url><loc>http://activeamericas.com/blog/gpcr/</loc></url><url><loc>http://activeamericas.com/blog/aurora-kinases/</loc></url><url><loc>http://activeamericas.com/blog/opportunistic-pathogens/</loc></url><url><loc>http://activeamericas.com/blog/allosteric-inhibitors-2/</loc></url><url><loc>http://activeamericas.com/blog/chemical-compounds/</loc></url><url><loc>http://activeamericas.com/blog/annotated-libraries/</loc></url><url><loc>http://activeamericas.com/blog/focused-library/</loc></url><url><loc>http://activeamericas.com/blog/medicinal-chemistry/</loc></url><url><loc>http://activeamericas.com/blog/drug-discovery/</loc></url><url><loc>http://activeamericas.com/blog/adme/</loc></url><url><loc>http://activeamericas.com/blog/gpcr-libraries/</loc></url><url><loc>http://activeamericas.com/blog/targeted-libraries/</loc></url><url><loc>http://activeamericas.com/blog/for-supplier-chemical-vendors/</loc></url><url><loc>http://activeamericas.com/blog/chemdivs-library-in-significant-research/</loc></url><url><loc>http://activeamericas.com/blog/cognixion-receives-fda-breakthrough-device-designation-for-assisted-communication-device/</loc></url><url><loc>http://activeamericas.com/blog/boehringer-ingelheim-earns-breakthrough-therapy-designation-for-pustular-psoriasis-drug/</loc></url><url><loc>http://activeamericas.com/blog/vertex-secures-fda-clearance-for-infants-cystic-fibrosis-therapy/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-first-ever-rsv-vaccine-after-brutal-2022-season/</loc></url><url><loc>http://activeamericas.com/blog/merck-agrees-to-build-bioprocessing-production-plant-in-south-korea/</loc></url><url><loc>http://activeamericas.com/blog/alzheimers-drug-developed-by-lilly-slows-cognitive-decline-by-35-pct/</loc></url><url><loc>http://activeamericas.com/blog/with-fda-nod-for-lumryz-avadel-is-set-to-jazz-up-the-narcolepsy-market/</loc></url><url><loc>http://activeamericas.com/blog/teva-medincell-win-fda-approval-for-slow-release-schizophrenia-drug-uzedy/</loc></url><url><loc>http://activeamericas.com/blog/fda-turns-back-ascendis-hormone-drug-over-manufacturing-issues/</loc></url><url><loc>http://activeamericas.com/blog/danahers-aldevron-unit-plots-mrna-manufacturing-expansion/</loc></url><url><loc>http://activeamericas.com/blog/dr-reddys-laboratories-announces-the-launch-of-treprostinil-injection-in-the-u-s/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-drug-which-helps-to-slow-progression-of-rare-form-of-mnd/</loc></url><url><loc>http://activeamericas.com/blog/national-institute-for-health-and-care-excellence-approves-expanded-use-of-yescarta-and-tecartus/</loc></url><url><loc>http://activeamericas.com/blog/chmp-recommends-approval-for-gsks-rsv-vaccine-candidate/</loc></url><url><loc>http://activeamericas.com/blog/janssen-gets-eu-approval-for-prostate-cancer-drug-akeega/</loc></url><url><loc>http://activeamericas.com/blog/trefoil-therapeutics-reports-new-findings-from-fecd-therapy-trial/</loc></url><url><loc>http://activeamericas.com/blog/avidity-biosciences-inc-granted-fda-fast-track-designation-for-antibody-aoc-1044/</loc></url><url><loc>http://activeamericas.com/blog/astrazeneca-and-ionis-attrv-pn-therapy-meets-trial-endpoints/</loc></url><url><loc>http://activeamericas.com/blog/xortx-gets-orphan-drug-nod-for-polycystic-kidney-disease/</loc></url><url><loc>http://activeamericas.com/blog/trinity-team-develops-promising-gene-therapy-for-glaucoma/</loc></url><url><loc>http://activeamericas.com/blog/a-gene-involved-in-down-syndrome-puts-the-brakes-on-neurons-activity-in-mice-new-study-shows/</loc></url><url><loc>http://activeamericas.com/blog/sleeping-pill-reduces-levels-of-alzheimers-proteins/</loc></url><url><loc>http://activeamericas.com/blog/university-of-rochester-researchers-discover-how-to-steer-army-of-immune-cells-toward-cancer/</loc></url><url><loc>http://activeamericas.com/blog/fda-expands-abbvies-abbv-qulipta-label-in-chronic-migraine/</loc></url><url><loc>http://activeamericas.com/blog/acadia-commercialises-first-us-rett-syndrome-drug/</loc></url><url><loc>http://activeamericas.com/blog/gamida-cell-receives-fda-approval-for-blood-cancer-therapy/</loc></url><url><loc>http://activeamericas.com/blog/agenus-rises-on-fast-track-tag-for-cancer-combo-drug/</loc></url><url><loc>http://activeamericas.com/blog/agenus-rises-on-fast-track-tag-for-cancer-combo-drug-2/</loc></url><url><loc>http://activeamericas.com/blog/omega-3-fatty-acids-might-reduce-cognitive-decline-risk/</loc></url><url><loc>http://activeamericas.com/blog/pipeline-therapeutics-announces-global-license-and-development-agreement-for-investigational-neuroscience-therapy-pipe-307/</loc></url><url><loc>http://activeamericas.com/blog/fda-updates-safety-labeling-and-prescribing-information-for-opioid-pain-meds/</loc></url><url><loc>http://activeamericas.com/blog/regenxbio-gene-therapy-candidate-gets-fast-track-status-for-duchenne-muscular-dystrophy/</loc></url><url><loc>http://activeamericas.com/blog/biogen-to-develop-amyloid-beta-targeting-antibody-platform/</loc></url><url><loc>http://activeamericas.com/blog/sumitomo-pharmas-ewing-sarcoma-candidate-gains-orphan-drug-status/</loc></url><url><loc>http://activeamericas.com/blog/potential-nitrosamine-contamination-results-in-another-voluntary-pharmaceutical-recall/</loc></url><url><loc>http://activeamericas.com/blog/idorsia-urges-dea-to-deschedule-chronic-insomnia-drug-class/</loc></url><url><loc>http://activeamericas.com/blog/us-fda-advisers-to-weigh-full-approval-for-eisai-biogens-alzheimers-drug/</loc></url><url><loc>http://activeamericas.com/blog/merck-eisai-decide-to-discontinue-advanced-melanoma-therapy-trial/</loc></url><url><loc>http://activeamericas.com/blog/shionogi-secures-fast-track-designation-for-investigational-covid-19-drug/</loc></url><url><loc>http://activeamericas.com/blog/signs-of-change-in-korean-diabetes-treatment-market/</loc></url><url><loc>http://activeamericas.com/blog/caribous-car-t-cell-therapy-receives-fast-track-status/</loc></url><url><loc>http://activeamericas.com/blog/enrollment-and-topline-data-expected-sooner-for-phase-3-trial-of-pitolisant-in-idiopathic-hypersomnia/</loc></url><url><loc>http://activeamericas.com/blog/eisai-presents-new-phase-3-analyses-of-aria-and-quality-of-life-of-lecanemab-treated-patients/</loc></url><url><loc>http://activeamericas.com/blog/camber-pharmaceuticals-recalls-antifungal-drug-due-to-contamination-risk/</loc></url><url><loc>http://activeamericas.com/blog/ema-highlights-trial-innovation-real-world-data-advances/</loc></url><url><loc>http://activeamericas.com/blog/viatris-cipla-and-aurobindo-sign-up-to-make-generics-of-gsks-long-acting-hiv-prep-drug/</loc></url><url><loc>http://activeamericas.com/blog/eu-approves-amicus-therapeutics-pombiliti-for-late-onset-pompe-disease/</loc></url><url><loc>http://activeamericas.com/blog/astrazeneca-amgens-asthma-launch-tezspire-picks-up-backing-from-englands-nice/</loc></url><url><loc>http://activeamericas.com/blog/cyclerions-mitochondrial-diseases-candidate-gets-orphan-drug-nod/</loc></url><url><loc>http://activeamericas.com/blog/glenmark-pharmaceuticals-generic-of-leo-pharmas-enstilar-approved/</loc></url><url><loc>http://activeamericas.com/blog/incyte-gets-crl-for-jakafi-extended-release-tablets/</loc></url><url><loc>http://activeamericas.com/blog/nice-recommends-upstaza-for-rare-genetic-disorder/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-first-ever-treatment-for-activated-phosphoinositide-3-kinase-delta-syndrome/</loc></url><url><loc>http://activeamericas.com/blog/astrazeneca-and-ionis-build-case-for-amyloidosis-drug-eplontersen/</loc></url><url><loc>http://activeamericas.com/blog/abbvie-hits-snag-for-parkinsons-disease-candidate/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-sandozs-citrate-free-adalimubab-formulation/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-rezzayo-a-novel-echinocandin/</loc></url><url><loc>http://activeamericas.com/blog/eu-authorizes-dupixent-for-young-kids-with-severe-atopic-dermatitis/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-evkeeza-for-kids-with-ultra-rare-cholesterol-disorder/</loc></url><url><loc>http://activeamericas.com/blog/us-fda-declines-to-approve-abbvies-parkinsons-disease-therapy/</loc></url><url><loc>http://activeamericas.com/blog/fusion-pharmaceuticals-announces-first-patient-dosed-in-phase-1-study-of-fpi-2059-a-targeted-alpha-therapy-tat-for-the-treatment-of-solid-tumors-expressing-ntsr1/</loc></url><url><loc>http://activeamericas.com/blog/fda-offers-advice-on-ndas-for-postoperative-local-anesthetics/</loc></url><url><loc>http://activeamericas.com/blog/fda-green-lights-clinical-trial-of-low-dose-psilocybin/</loc></url><url><loc>http://activeamericas.com/blog/xtandi-shows-promise-in-prostate-cancer-trial/</loc></url><url><loc>http://activeamericas.com/blog/mayo-clinic-cancer-expert-highlights-advancements-in-treating-multiple-myeloma/</loc></url><url><loc>http://activeamericas.com/blog/paxlovid-gets-advisory-panel-support-for-full-fda-approval/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-novartis-treatment-combination-for-pediatric-glioma/</loc></url><url><loc>http://activeamericas.com/blog/integrated-drug-discovery-cro-services-for-pharmaceutical-rd/</loc></url><url><loc>http://activeamericas.com/blog/fda-offers-advice-on-ndas-for-postoperative-local-anesthetics-2/</loc></url><url><loc>http://activeamericas.com/blog/fda-will-retain-some-guidances-after-end-to-covid-emergency/</loc></url><url><loc>http://activeamericas.com/blog/fda-offers-advice-on-ndas-for-postoperative-local-anesthetics-3/</loc></url><url><loc>http://activeamericas.com/blog/positive-phase-2-data-from-atrial-fibrillation-clinical-trial-primary-endpoint-met/</loc></url><url><loc>http://activeamericas.com/blog/formology-lab-gets-warning-letter-for-lax-identity-testing-other-lapses/</loc></url><url><loc>http://activeamericas.com/blog/ellipses-pharmas-acute-myeloid-leukemia-candidate-gets-orphan-drug-nod/</loc></url><url><loc>http://activeamericas.com/blog/satellos-bioscience-announces-further-preclinical-progress-with-sat-3153-as-a-potential-treatment-for-duchenne-muscular-dystrophy/</loc></url><url><loc>http://activeamericas.com/blog/us-fda-approves-acadia-pharmaceuticals-rett-syndrome-therapy/</loc></url><url><loc>http://activeamericas.com/blog/solanezumab-fails-to-halt-amyloid-and-cognitive-decline-in-preclinical-alzheimers/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-pfizers-zavzpret-in-acute-treatment-of-migraine/</loc></url><url><loc>http://activeamericas.com/blog/despite-fda-doubts-advisors-back-first-line-polivy-use/</loc></url><url><loc>http://activeamericas.com/blog/innocare-announces-first-subject-dosed-in-clinical-trial-of-bcl2-inhibitor-icp-248-in-china/</loc></url><url><loc>http://activeamericas.com/blog/tagrisso-demonstrated-strong-overall-survival-benefit-in-the-adaura-phase-iii-trial-for-adjuvant-treatment-of-patients-with-early-stage-egfr-mutated-lung-cancer/</loc></url><url><loc>http://activeamericas.com/blog/fda-accepts-ionis-nda-for-eplontersen-in-rare-hereditary-disease/</loc></url><url><loc>http://activeamericas.com/blog/fda-expands-approval-of-eli-lillys-verzenio-for-high-risk-early-breast-cancer/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-im-administration-of-mercks-mmrv-family-of-vaccines/</loc></url><url><loc>http://activeamericas.com/blog/mercks-mk-0616-an-investigational-oral-pcsk9-inhibitor-significantly-reduced-ldl-c-in-patients-with-hypercholesterolemia-in-phase-2b-study/</loc></url><url><loc>http://activeamericas.com/blog/fda-denies-petition-to-grant-simufilam-breakthrough-designation/</loc></url><url><loc>http://activeamericas.com/blog/astrazeneca-says-cancer-drug-enhertu-showed-positive-results/</loc></url><url><loc>http://activeamericas.com/blog/future-of-generative-ai-in-pharma/</loc></url><url><loc>http://activeamericas.com/blog/exelixis-provides-update-on-phase-3-contact-03-trial-evaluating-cabozantinib-in-combination-with-atezolizumab-in-patients-with-previously-treated-advanced-kidney-cancer/</loc></url><url><loc>http://activeamericas.com/blog/forcast-orthopedics-gets-qidp-nod-for-investigational-antibiotic/</loc></url><url><loc>http://activeamericas.com/blog/gene-therapy-consortium-to-launch-rare-diseases-pilot/</loc></url><url><loc>http://activeamericas.com/blog/fdas-approval-of-friedreichs-ataxia-drug-is-a-game-changer-for-treatment-of-rare-diseases/</loc></url><url><loc>http://activeamericas.com/blog/fda-offers-advice-on-macular-degeneration-drug-trials/</loc></url><url><loc>http://activeamericas.com/blog/fda-accepts-ind-and-grants-priority-review-for-springworks-desmoid-tumors-therapeutic/</loc></url><url><loc>http://activeamericas.com/blog/unexplored-chemical-space-medium-and-large-sized-%ce%b2-alanine-based-lactams/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-sanofi-and-sobis-altuviiio-for-hemophilia-a/</loc></url><url><loc>http://activeamericas.com/blog/beyond-binary-scaled-molecular-fingerprints-for-maximum-diversity-picking/</loc></url><url><loc>http://activeamericas.com/blog/synthesis-and-cytotoxic-properties-of-novel-derivatives-of-noscapine/</loc></url><url><loc>http://activeamericas.com/blog/a-helix-3-d-mimetics-library/</loc></url><url><loc>http://activeamericas.com/blog/first-principle-concept-in-designing-small-molecules-for-targeting-rna-expansion-repeats/</loc></url><url><loc>http://activeamericas.com/blog/design-of-three-dimensional-core-building-blocks-adapted-for-decl-synthesis/</loc></url><url><loc>http://activeamericas.com/blog/macrocyclic-peptidomestics-library-design-and-synthesis/</loc></url><url><loc>http://activeamericas.com/blog/fda-creates-task-force-to-fast-track-covid-19-drugs-registration/</loc></url><url><loc>http://activeamericas.com/blog/alzheimers-antibody-therapy-from-eli-lilly-granted-us-fda-breakthrough-therapy-designation/</loc></url><url><loc>http://activeamericas.com/blog/eu-authorizes-csls-gene-therapy-for-hemophilia-b/</loc></url><url><loc>http://activeamericas.com/blog/title-protecting-copd-patients-theravance-and-viatris-aim-to-prevent-generic-versions-of-vital-drug/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-austedo-xr-extended-release-tablets-for-huntingtons-disease/</loc></url><url><loc>http://activeamericas.com/blog/cognition-therapeutics-and-actc-receive-fda-clearance-for-phase-2-start-study-of-oral-ct1812-in-early-alzheimers-disease/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-first-treatment-for-geographic-atrophy-accepts-nda-for-same-indication/</loc></url><url><loc>http://activeamericas.com/blog/lagevrio-disappoints-in-phase-3-study-for-post-exposure-prevention-of-covid-19/</loc></url><url><loc>http://activeamericas.com/blog/modus-therapeutics-announces-positive-topline-data-from-its-phase-1b-lps-provocation-study-evaluating-the-potential-of-sevuparin-for-treatment-of-sepsis/</loc></url><url><loc>http://activeamericas.com/blog/regeneron-is-off-to-chaple-as-fda-starts-pozelimab-review/</loc></url><url><loc>http://activeamericas.com/blog/fda-accepts-two-sndas-for-mercks-prevymis/</loc></url><url><loc>http://activeamericas.com/blog/moderna-announces-interim-results-from-phase-3-safety-and-immunogenicity-trial-of-mrna-1010-vaccine-candidate/</loc></url><url><loc>http://activeamericas.com/blog/chiesi-groups-lamzede-gets-fda-approval-for-rare-genetic-disorder/</loc></url><url><loc>http://activeamericas.com/blog/covid-19-infection-can-increase-a-patients-risk-of-new-onset-diabetes/</loc></url><url><loc>http://activeamericas.com/blog/travere-therapeutics-announces-fda-accelerated-approval-of-filspari%e1%b5%80%e1%b4%b9-sparsentan-the-first-and-only-non-immunosuppressive-therapy-for-the-reduction-of-proteinuria-in-iga-nephropathy/</loc></url><url><loc>http://activeamericas.com/blog/maze-therapeutics-to-present-phase-1-results-from-first-in-human-trial-evaluating-mze001-as-a-potential-oral-treatment-for-pompe-disease/</loc></url><url><loc>http://activeamericas.com/blog/biocon-and-viatris-draw-complete-response-letter-for-bevacizumab-bla/</loc></url><url><loc>http://activeamericas.com/blog/kinnate-biopharma-gets-fast-track-status-for-bile-duct-cancer-candidate/</loc></url><url><loc>http://activeamericas.com/blog/labeling-changes-for-aduhelm-detail-risks-of-aria-brain-bleeds/</loc></url><url><loc>http://activeamericas.com/blog/soligenix-gets-refusal-to-file-letter-for-hybryte-in-cutaneous-t-cell-lymphoma/</loc></url><url><loc>http://activeamericas.com/blog/fda-places-partial-clinical-hold-on-blueprint-medicines-trial/</loc></url><url><loc>http://activeamericas.com/blog/ema-to-review-pseudoephedrine-drugs/</loc></url><url><loc>http://activeamericas.com/blog/frequency-therapeutics-announces-topline-results-for-its-phase-2b-study-of-fx-322-for-the-treatment-of-sensorineural-hearing-loss/</loc></url><url><loc>http://activeamericas.com/blog/gsks-jemperli-gets-regular-approval-for-endometrial-cancer/</loc></url><url><loc>http://activeamericas.com/blog/fda-accepts-biologics-license-application-for-proposed-biosimilar-denosumab/</loc></url><url><loc>http://activeamericas.com/blog/fda-extends-ibuprofen-suspension-guidance/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-regenerons-eylea-for-infants-with-rop/</loc></url><url><loc>http://activeamericas.com/blog/fda-expands-approval-for-takedas-takhzyro/</loc></url><url><loc>http://activeamericas.com/blog/mesoblast-cell-therapy-gets-rmat-designation-for-chronic-low-back-pain/</loc></url><url><loc>http://activeamericas.com/blog/ema-clarifies-its-policy-on-biosimilar-interchangeability/</loc></url><url><loc>http://activeamericas.com/blog/janssens-nipocalimab-shines-in-hdfn-trial/</loc></url><url><loc>http://activeamericas.com/blog/rocket-pharmaceuticals-gets-rmat-designation-for-danon-disease-gene-therapy/</loc></url><url><loc>http://activeamericas.com/blog/sage-and-biogens-depression-drug-candidate-gets-priority-review/</loc></url><url><loc>http://activeamericas.com/blog/roches-crovalimab-trial-reaches-endpoints-in-patients-with-pnh/</loc></url><url><loc>http://activeamericas.com/blog/daewoong-pharmaceutical-begins-the-first-administration-of-the-bersiporocin-new-treatment-for-idiopathic-pulmonary-fibrosis-as-phase-ii-clinical-trial/</loc></url><url><loc>http://activeamericas.com/blog/aldeyras-reproxalap-for-dry-eye-disease-accepted-by-fda/</loc></url><url><loc>http://activeamericas.com/blog/mesoblast-resubmits-bla-for-remestemcel-l/</loc></url><url><loc>http://activeamericas.com/blog/eisais-new-alzheimers-drug-leqembi-hits-the-u-s-market/</loc></url><url><loc>http://activeamericas.com/blog/ground-breaking-results-in-phase-2-scleroderma-study-by-certa-therapeutics-demonstrates-improvement-in-more-than-60-of-patients/</loc></url><url><loc>http://activeamericas.com/blog/gilead-buoyed-by-trodelvy-ok-in-new-breast-cancer-use/</loc></url><url><loc>http://activeamericas.com/blog/medicago-to-shut-down-despite-covid-19-vaccine-approval/</loc></url><url><loc>http://activeamericas.com/blog/icer-questions-benefit-of-fezolinetant-for-hot-flashes/</loc></url><url><loc>http://activeamericas.com/blog/jesduvroq-daprodustat-approved-by-us-fda-for-anaemia-of-chronic-kidney-disease-in-adults-on-dialysis/</loc></url><url><loc>http://activeamericas.com/blog/nice-recommends-epidyolex-for-tuberous-sclerosis-complex-seizures/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-sutimlimab-jome-with-long-term-safety-efficacy-data-for-cold-agglutinin-disease/</loc></url><url><loc>http://activeamericas.com/blog/eu-expands-dupixents-authorization-for-eosinophilic-esophagitis/</loc></url><url><loc>http://activeamericas.com/blog/roche-boehringer-tap-biosensor-firms-for-patient-studies/</loc></url><url><loc>http://activeamericas.com/blog/fda-grants-accelerated-approval-to-eli-lillys-jaypirca-in-mantle-cell-lymphoma/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-stemlines-orserdu-for-several-forms-of-breast-cancer/</loc></url><url><loc>http://activeamericas.com/blog/cassava-claims-phase-2-win-for-its-alzheimers-candidate/</loc></url><url><loc>http://activeamericas.com/blog/syros-gets-fast-track-status-for-higher-risk-myelodysplastic-syndrome-candidate/</loc></url><url><loc>http://activeamericas.com/blog/us-fda-clears-transcentas-ind-for-rett-syndrome-treatment/</loc></url><url><loc>http://activeamericas.com/blog/merck-finds-causes-of-nitrosamine-in-diabetes-drugs/</loc></url><url><loc>http://activeamericas.com/blog/nice-recommends-vutrisiran-for-transthyretin-related-amyloidosis/</loc></url><url><loc>http://activeamericas.com/blog/sun-pharma-to-buy-concert-pharma-gaining-potential-alopecia-areata-treatment/</loc></url><url><loc>http://activeamericas.com/blog/national-institutes-of-health-grant-to-fund-alzheimers-research/</loc></url><url><loc>http://activeamericas.com/blog/avidity-biosciences-gets-fast-track-for-facioscapulohumeral-muscular-dystrophy/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-adacel-vaccine-during-pregnancy-to-protect-infants-against-pertussis/</loc></url><url><loc>http://activeamericas.com/blog/orameds-oral-insulin-flunks-phase-3-diabetes-test-sending-stock-down-70/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-novo-nordisks-rybelsus-as-first-line-treatment-for-type-2-diabetes/</loc></url><url><loc>http://activeamericas.com/blog/hallucination-drug-could-help-treat-type-2-diabetes/</loc></url><url><loc>http://activeamericas.com/blog/luye-claims-its-first-fda-approval-for-bi-weekly-schizophrenia-drug/</loc></url><url><loc>http://activeamericas.com/blog/australian-scientists-closer-to-finding-new-lung-cancer-treatments/</loc></url><url><loc>http://activeamericas.com/blog/us-fda-approves-astrazeneca-avillions-asthma-treatment-airsupra/</loc></url><url><loc>http://activeamericas.com/blog/fda-rejects-biocon-insulin-biosimilar-over-data-manufacturing-concerns/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-foundationone-liquid-cdx-to-identify-genomic-profile-in-nsclc/</loc></url><url><loc>http://activeamericas.com/blog/fda-grants-priority-review-to-roches-glofitamab-bla-in-large-b-cell-lymphoma/</loc></url><url><loc>http://activeamericas.com/blog/acelyrin-acquires-valenzabio-strengthens-immunology-position/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-briumvi-for-relapsing-multiple/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-actemra-for-hospitalized-adults-with-covid-19/</loc></url><url><loc>http://activeamericas.com/blog/fda-slaps-partial-hold-on-biogen-innocare-ms-drug/</loc></url><url><loc>http://activeamericas.com/blog/az-announces-us-fast-track-designation-for-il-5-inhibitor-fasenra/</loc></url><url><loc>http://activeamericas.com/blog/roches-lunsumio-gets-accelerated-approval-for-later-line-follicular-lymphoma/</loc></url><url><loc>http://activeamericas.com/blog/study-results-show-direct-evidence-of-serotonin-disruption-linked-with-depression/</loc></url><url><loc>http://activeamericas.com/blog/new-method-predicts-the-right-treatment-for-breast-cancer-patients/</loc></url><url><loc>http://activeamericas.com/blog/gilead-sciences-sunlenca-gains-fda-approval-for-hiv-type-1/</loc></url><url><loc>http://activeamericas.com/blog/study-survivors-of-hodgkin-lymphoma-show-signs-of-dementia-in-early-adulthood/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-tocilizumab-as-first-monoclonal-antibody-treatment-of-covid-19/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-bispecific-antibody-mosunetuzumab-axgb-to-treat-relapsed-refractory-follicular-lymphoma/</loc></url><url><loc>http://activeamericas.com/blog/eu-approves-ataras-ebvallo-for-posttransplant-lymphoproliferative-disease/</loc></url><url><loc>http://activeamericas.com/blog/fda-grants-priority-review-for-enfortumab-vedotin-ejfv-pembrolizumab-for-treatment-of-urothelial-cancer/</loc></url><url><loc>http://activeamericas.com/blog/pfizer-files-blockbuster-hope-etrasimod-for-ulcerative-colitis/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-preservative-free-latanoprost-drug-for-elevated-intraocular-pressure/</loc></url><url><loc>http://activeamericas.com/blog/a-way-to-make-asthma-drugs-last-longer/</loc></url><url><loc>http://activeamericas.com/blog/fda-pauses-ind-submission-for-duchenne-therapy-entr-601-44/</loc></url><url><loc>http://activeamericas.com/blog/fda-expands-approval-for-cytalux-imaging-for-lung-cancer-detection/</loc></url><url><loc>http://activeamericas.com/blog/abbvies-vraylar-gets-expanded-approval-for-major-depressive-disorder/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-first-gene-therapy-for-specific-form-of-bladder-cancer/</loc></url><url><loc>http://activeamericas.com/blog/neurophth-receives-ind-clearance-from-fda-for-aav-nd1-gene-therapy-of-lhon/</loc></url><url><loc>http://activeamericas.com/blog/kintaras-val-083-gets-orphan-drug-status-for-rare-childhood-cancer/</loc></url><url><loc>http://activeamericas.com/blog/prime-to-cover-biosimilars-alongside-humira/</loc></url><url><loc>http://activeamericas.com/blog/intranasal-therapy-for-major-depressive-disorder-gets-fast-track-status/</loc></url><url><loc>http://activeamericas.com/blog/fda-advisors-reject-cytokinetics-heart-failure-candidate/</loc></url><url><loc>http://activeamericas.com/blog/merck-and-modernas-mrna-cancer-vaccine-aces-its-first-efficacy-trial/</loc></url><url><loc>http://activeamericas.com/blog/rare-disease-moonshot-launched-at-european-health-summit/</loc></url><url><loc>http://activeamericas.com/blog/miratis-krazati-gets-accelerated-approval-for-nsclc/</loc></url><url><loc>http://activeamericas.com/blog/british-pharma-industry-cites-six-companies-for-code-violations/</loc></url><url><loc>http://activeamericas.com/blog/ash-cd20-bispecific-antibodies-take-centre-stage-in-lymphoma/</loc></url><url><loc>http://activeamericas.com/blog/moleculin-biotechs-wp1122-receives-fast-track-status-for-glioblastoma/</loc></url><url><loc>http://activeamericas.com/blog/the-effect-of-aging-in-multiple-sclerosis-and-the-model-of-care/</loc></url><url><loc>http://activeamericas.com/blog/sabcs-pharmas-show-their-working-in-hr-her2-breast-cancer/</loc></url><url><loc>http://activeamericas.com/blog/istessos-idiopathic-pulmonary-fibrosis-candidate-gains-fast-track/</loc></url><url><loc>http://activeamericas.com/blog/eu-approves-takedas-dengue-vaccine/</loc></url><url><loc>http://activeamericas.com/blog/olutasidenib-gains-fda-approval-for-idh1-mutated-relapsed-refractory-acute-myeloid-leukemia/</loc></url><url><loc>http://activeamericas.com/blog/ifenprodil-for-ipf-earns-orphan-drug-designation/</loc></url><url><loc>http://activeamericas.com/blog/pfizers-bla-for-its-rsv-vaccine-gets-priority-review/</loc></url><url><loc>http://activeamericas.com/blog/donanemab-shows-greater-ability-to-clear-amyloid-plaque-than-aducanumab/</loc></url><url><loc>http://activeamericas.com/blog/addressing-unmet-needs-of-dementia-with-lewy-bodies/</loc></url><url><loc>http://activeamericas.com/blog/x4-pharmaceuticals-announces-positive-top-line-results-for-whim-syndrome-drug/</loc></url><url><loc>http://activeamericas.com/blog/ananda-scientific-announces-fda-approval-of-the-ind-for-a-clinical-trial-exploring-treatment-of-social-anxiety-disorder-sad/</loc></url><url><loc>http://activeamericas.com/blog/axs-05-meets-primary-end-point-in-phase-3-trial-of-alzheimer-agitation/</loc></url><url><loc>http://activeamericas.com/blog/full-life-technologies-acquires-focus-x-therapeutics/</loc></url><url><loc>http://activeamericas.com/blog/fda-delays-decision-date-on-gamida-cell-bla/</loc></url><url><loc>http://activeamericas.com/blog/eu-launches-ai-powered-real-world-data-project-for-cancer-therapies/</loc></url><url><loc>http://activeamericas.com/blog/chemotherapy-could-increase-disease-susceptibility-in-future-generations/</loc></url><url><loc>http://activeamericas.com/blog/senators-introduce-new-bill-to-promote-research-and-access-to-mdma-psilocybin/</loc></url><url><loc>http://activeamericas.com/blog/ec-grants-approval-for-abbvies-skyrizi-to-treat-crohns-disease/</loc></url><url><loc>http://activeamericas.com/blog/new-crispr-based-tool-inserts-large-dna-sequences-at-desired-sites-in-cells/</loc></url><url><loc>http://activeamericas.com/blog/biovac-and-ivi-enter-deal-to-develop-oral-cholera-vaccine/</loc></url><url><loc>http://activeamericas.com/blog/diagnostic-marker-found-for-deadly-brain-disease-marked-by-dementia-movement-problems-discovery-could-accelerate-progress-toward-therapies-for-primary-tauopathies/</loc></url><url><loc>http://activeamericas.com/blog/fda-grants-breakthrough-therapy-status-to-iveric-bios-zimura-for-amd/</loc></url><url><loc>http://activeamericas.com/blog/nona-and-dragonfly-enter-hcab-based-drug-discovery-partnership/</loc></url><url><loc>http://activeamericas.com/blog/anti-amyloid-s-oligomer-antibody-acu193-gains-fda-fast-track-designation/</loc></url><url><loc>http://activeamericas.com/blog/regeneron-cytomx-announce-bispecific-therapeutics-for-cancer-collab/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-second-interchangeable-insulin-product-rezvoglar-insulin-glargine-aglr/</loc></url><url><loc>http://activeamericas.com/blog/tzield-drug-that-can-delay-onset-of-type-1-diabetes-has-a-pricetag-close-to-200000/</loc></url><url><loc>http://activeamericas.com/blog/camber-pharmaceuticals-launches-generic-lamictal-xr/</loc></url><url><loc>http://activeamericas.com/blog/novel-ai-blood-test-detects-liver-cancer/</loc></url><url><loc>http://activeamericas.com/blog/fda-panel-backs-ardelyx-ckd-drug-despite-agency-concerns/</loc></url><url><loc>http://activeamericas.com/blog/fda-may-approve-naloxone-for-nonprescription-use/</loc></url><url><loc>http://activeamericas.com/blog/vistagen-announces-publication-in-cells-demonstrating-av-101s-potential-for-treating-levodopa-induced-dyskinesia-in-patients-with-parkinsons-disease/</loc></url><url><loc>http://activeamericas.com/blog/canbridge-pharmaceuticals-granted-orphan-drug-designation-for-can-106-for-the-treatment-of-myasthenia-gravis/</loc></url><url><loc>http://activeamericas.com/blog/walmart-enters-settlement-agreement-over-opioid-lawsuits-joining-cvs-and-walgreens/</loc></url><url><loc>http://activeamericas.com/blog/abbvie-reaches-54-4-million-settlement-over-its-alzheimers-drug/</loc></url><url><loc>http://activeamericas.com/blog/how-high-blood-sugar-really-causes-type-2-diabetes-chemicals-produced-when-glucose-is-broken-down-are-to-blame-study-finds/</loc></url><url><loc>http://activeamericas.com/blog/seagens-adcetris-gains-expanded-label-for-pediatric-cancer-patients/</loc></url><url><loc>http://activeamericas.com/blog/gsk-limits-ovarian-cancer-drugs-indication/</loc></url><url><loc>http://activeamericas.com/blog/satsuma-sts101-migraine-candidate-fails-late-stage-trial/</loc></url><url><loc>http://activeamericas.com/blog/fda-accepts-new-drug-application-for-zilucoplan-for-generalized-myasthenia-gravis/</loc></url><url><loc>http://activeamericas.com/blog/stada-and-xbrane-get-eu-approval-for-lucentis-biosimilar-for-eye-disease/</loc></url><url><loc>http://activeamericas.com/blog/fda-approves-astrazenecas-imfinzi-and-imjudo-for-stage-4-nsclc/</loc></url><url><loc>http://activeamericas.com/blog/eqrx-drops-u-s-plans-for-nsclc-therapy/</loc></url><url><loc>http://activeamericas.com/blog/fda-grants-sobi-emergency-authorization-for-kineret-to-treat-covid-19/</loc></url><url><loc>http://activeamericas.com/blog/uk-allows-interchangeability-of-biosimilars/</loc></url><url><loc>http://activeamericas.com/blog/pharmacogenomics-offers-a-glimpse-into-the-future-of-pharmacy/</loc></url><url><loc>http://activeamericas.com/blog/fda-panel-backs-azs-pt027-asthma-rescue-drug-but-in-adults-only/</loc></url></urlset>
